Retraction of high-profile paper on cancer drug timing could hand ammo to China hawks - Endpoints News

Retraction of high-profile paper on cancer drug timing could hand ammo to China hawks  Endpoints NewsMedical Journal Retracts Study Claiming Cancer Therapy Is More Effective When Given in the Morning  The New York TimesNature retracts provocative PD-1 study that tied lung cancer survival to treatment timing  Fierce PharmaDiscussions Around Retraction of Debated Study on Early Morning Immunotherapy Benefits  OncodailyNature Medicine Retracts Viral Lung Cancer Timing Study After Four-Month Investigation  Applied Clinical Trials Online